A heterodinucleotide comprising BVDU and Gemcitabine bound together by a 5′, 5′- pyrophospate bridge (BVDUp2dFdC) has been synthesized and evaluated as antitumor agent against AH13 rat sarcoma cells. BVDUp2dFdC showed a cytotoxicity similar to that of Gemcitabine.